|
n
| 544 452 (92.9%) | 41 919 (7.1%) | 586 371 (100.0%) | |
|
Age groups, years
| |
| 16-25 | 77 706 (14.3%) | 4531 (10.8%) | 82 237 (14.0%) | <0.001 |
| 26-35 | 70 625 (13.0%) | 6532 (15.6%) | 77 157 (13.2%) | |
| 36-45 | 58 752 (10.8%) | 5300 (12.6%) | 64 052 (10.9%) | |
| 46-55 | 68 024 (12.5%) | 6188 (14.8%) | 74 212 (12.7%) | |
| 56-65 | 74 158 (13.6%) | 5973 (14.2%) | 80 131 (13.7%) | |
| 66-75 | 94 846 (17.4%) | 6256 (14.9%) | 101 102 (17.2%) | |
| 76-85 | 72 064 (13.2%) | 4898 (11.7%) | 76 962 (13.1%) | |
| 86-95 | 26 745 (4.9%) | 2098 (5.0%) | 28 843 (4.9%) | |
| ≥96 | 1532 (0.3%) | 143 (0.3%) | 1675 (0.3%) | |
|
Year
| |
| 2018 | 144 064 (26.5%) | 744 (1.8%) | 144 808 (24.7%) | <0.001 |
| 2019 | 150 296 (27.6%) | 1429 (3.4%) | 151 725 (25.9%) | |
| 2020 | 128 016 (23.5%) | 17 803 (42.5%) | 145 819 (24.9%) | |
| 2021 | 122 076 (22.4%) | 21 943 (52.3%) | 144 019 (24.6%) | |
|
Pregnancy registered within the calendar year of the index consultation
| |
| Not pregnant | 523 342 (96.1%) | 39 545 (94.3%) | 562 887 (96.0%) | <0.001 |
| Pregnant | 21 110 (3.9%) | 2374 (5.7%) | 23 484 (4.0%) | |
|
Multimorbidity registered within the calendar year of the index consultation
| |
| No other morbidities | 469 432 (86.2%) | 34 838 (83.1%) | 504 270 (86.0%) | <0.001 |
| Other morbidity | 75 020 (13.8%) | 7081 (16.9%) | 82 101 (14.0%) | |
|
Recurrent cystitis in the calendar year of the acute cystitis episode
| | | |
| <3 cystitis episodes per year | 511 394 (93.9%) | 38 745 (92.4%) | 550 139 (93.8%) | <0.001 |
|
>3 cystitis episodes per year | 33 058 (6.1%) | 3174 (7.6%) | 36 232 (6.2%) | |
|
Antibiotics or not dispensed <3 days following index consultation
| |
| No antibiotic treatment | 114 845 (21.1%) | 9750 (23.3%) | 124 595 (21.2%) | <0.001 |
| Antibiotic treatment | 429 607 (78.9%) | 32 169 (76.7%) | 461 776 (78.8%) | |
|
Types of antibiotics dispensed <3 days following index consultation
| |
| First-line | 299 961 (69.8%) | 21 987 (68.3%) | 321 948 (69.7%) | <0.001 |
| Second-line | 129 646 (30.2%) | 10 182 (31.7%) | 139 828 (30.3%) | |
|
Repeat contact <14 days following index-consultation
| |
| No repeat contact | 418 374 (76.8%) | 31 134 (74.3%) | 449 508 (76.7%) | <0.001 |
| Repeat contact | 126 078 (23.2%) | 10 785 (25.7%) | 136 863 (23.3%) | |
|
Type of repeat contact <14 days following index-consultation
| |
| In-person consultation | 51 232 (40.6%) | 2655 (24.6%) | 53 887 (39.4%) | <0.001 |
| Remote consultation | 6273 (5.0%) | 3133 (29.0%) | 9 406 (6.9%) | |
| Simple contact | 68 573 (54.4%) | 4997 (46.3%) | 73 570 (53.8%) | |
|
Antibiotics or not dispensed <3 days following repeat contact
| |
| No antibiotic treatment | 71 693 (56.9%) | 5959 (55.3%) | 77 652 (56.7%) | <0.001 |
| Antibiotic treatment | 54 385 (43.1%) | 4826 (44.7%) | 59 211 (43.3%) | |
|
If antibiotic treatment <3 days following index consultation and <3 days following repeat contact, antibiotic switch?
| |
| Same antibiotic repeated | 33 284 (26.4%) | 3910 (36.3%) | 37 194 (27.2%) | <0.001 |
| Different antibiotic | 92 794 (73.6%) | 6875 (63.7%) | 99 669 (72.8%) | |
|
Pyelonephritis contact <14 days following index consultation
| |
| Not pyelonephritis | 123 823 (98.2%) | 10 679 (99.0%) | 134 502 (98.3%) | <0.001 |
| Pyelonephritis | 2255 (1.8%) | 106 (1.0%) | 2 361 (1.7%) | |